GEMINI SPACE STATION INC-A (GEMI) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:GEMI • US36866J1051

7.55 USD
-0.07 (-0.92%)
At close: Feb 3, 2026
7.53 USD
-0.02 (-0.26%)
After Hours: 2/3/2026, 8:20:35 PM
Fundamental Rating

2

Taking everything into account, GEMI scores 2 out of 10 in our fundamental rating. GEMI was compared to 238 industry peers in the Capital Markets industry. GEMI has a bad profitability rating. Also its financial health evaluation is rather negative. GEMI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • GEMI had negative earnings in the past year.
GEMI Yearly Net Income VS EBIT VS OCF VS FCFGEMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 -100M -200M -300M

1.2 Ratios

  • GEMI has a Return On Assets of -20.06%. This is amonst the worse of the industry: GEMI underperforms 87.82% of its industry peers.
  • GEMI's Return On Equity of -71.76% is on the low side compared to the rest of the industry. GEMI is outperformed by 86.13% of its industry peers.
Industry RankSector Rank
ROA -20.06%
ROE -71.76%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GEMI Yearly ROA, ROE, ROICGEMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 100 -100 200

1.3 Margins

  • GEMI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GEMI Yearly Profit, Operating, Gross MarginsGEMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 -100 -200 -300

3

2. Health

2.1 Basic Checks

  • GEMI has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for GEMI is higher compared to a year ago.
GEMI Yearly Shares OutstandingGEMI Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 20M 40M 60M 80M 100M
GEMI Yearly Total Debt VS Total AssetsGEMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 500M 1B 1.5B

2.2 Solvency

  • Based on the Altman-Z score of -0.85, we must say that GEMI is in the distress zone and has some risk of bankruptcy.
  • GEMI's Altman-Z score of -0.85 is on the low side compared to the rest of the industry. GEMI is outperformed by 84.87% of its industry peers.
  • GEMI has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.37, GEMI is in the better half of the industry, outperforming 69.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z -0.85
ROIC/WACCN/A
WACCN/A
GEMI Yearly LT Debt VS Equity VS FCFGEMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 200M -200M 400M

2.3 Liquidity

  • GEMI has a Current Ratio of 1.29. This is a normal value and indicates that GEMI is financially healthy and should not expect problems in meeting its short term obligations.
  • GEMI's Current ratio of 1.29 is fine compared to the rest of the industry. GEMI outperforms 60.08% of its industry peers.
  • GEMI has a Quick Ratio of 1.29. This is a normal value and indicates that GEMI is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of GEMI (1.29) is better than 60.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
GEMI Yearly Current Assets VS Current LiabilitesGEMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

  • The earnings per share for GEMI have decreased strongly by -306.36% in the last year.
  • The Revenue has grown by 29.46% in the past year. This is a very strong growth!
EPS 1Y (TTM)-306.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-765.66%
Revenue 1Y (TTM)29.46%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%106.25%

3.2 Future

  • GEMI is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -7.50% yearly.
  • GEMI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 50.80% yearly.
EPS Next Y-337.54%
EPS Next 2Y-44.79%
EPS Next 3Y-7.5%
EPS Next 5YN/A
Revenue Next Year21.74%
Revenue Next 2Y49.98%
Revenue Next 3Y50.8%
Revenue Next 5YN/A

3.3 Evolution

GEMI Yearly Revenue VS EstimatesGEMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 100M 200M 300M 400M
GEMI Yearly EPS VS EstimatesGEMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -1 -2 -3 -4 -5

0

4. Valuation

4.1 Price/Earnings Ratio

  • GEMI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GEMI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GEMI Price Earnings VS Forward Price EarningsGEMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GEMI Per share dataGEMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

  • A cheap valuation may be justified as GEMI's earnings are expected to decrease with -7.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-44.79%
EPS Next 3Y-7.5%

0

5. Dividend

5.1 Amount

  • GEMI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

GEMINI SPACE STATION INC-A

NASDAQ:GEMI (2/3/2026, 8:20:35 PM)

After market: 7.53 -0.02 (-0.26%)

7.55

-0.07 (-0.92%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-10
Earnings (Next)N/A
Inst Owners31.14%
Inst Owner Change-6.36%
Ins Owners7.45%
Ins Owner Change100%
Market Cap888.26M
Revenue(TTM)162.53M
Net Income(TTM)-468.98M
Analysts76.25
Price Target23.05 (205.3%)
Short Float %18.57%
Short Ratio3.66
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.39%
PT rev (3m)N/A
EPS NQ rev (1m)-1.5%
EPS NQ rev (3m)-82.76%
EPS NY rev (1m)-7.02%
EPS NY rev (3m)-56.15%
Revenue NQ rev (1m)-5.36%
Revenue NQ rev (3m)-12.21%
Revenue NY rev (1m)-1.76%
Revenue NY rev (3m)-1.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.47
P/FCF N/A
P/OCF N/A
P/B 1.36
P/tB 1.75
EV/EBITDA N/A
EPS(TTM)-9.31
EYN/A
EPS(NY)-2.83
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.38
BVpS5.56
TBVpS4.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.06%
ROE -71.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z -0.85
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-306.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-765.66%
EPS Next Y-337.54%
EPS Next 2Y-44.79%
EPS Next 3Y-7.5%
EPS Next 5YN/A
Revenue 1Y (TTM)29.46%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%106.25%
Revenue Next Year21.74%
Revenue Next 2Y49.98%
Revenue Next 3Y50.8%
Revenue Next 5YN/A
EBIT growth 1Y2.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-51.64%
EBIT Next 3Y17.84%
EBIT Next 5YN/A
FCF growth 1Y46.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.44%
OCF growth 3YN/A
OCF growth 5YN/A

GEMINI SPACE STATION INC-A / GEMI FAQ

What is the ChartMill fundamental rating of GEMINI SPACE STATION INC-A (GEMI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to GEMI.


What is the valuation status of GEMINI SPACE STATION INC-A (GEMI) stock?

ChartMill assigns a valuation rating of 0 / 10 to GEMINI SPACE STATION INC-A (GEMI). This can be considered as Overvalued.


Can you provide the profitability details for GEMINI SPACE STATION INC-A?

GEMINI SPACE STATION INC-A (GEMI) has a profitability rating of 0 / 10.